Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dare Bioscience, Inc. Proxy Solicitation & Information Statement 2018

May 31, 2018

34825_rns_2018-05-31_4a465a6d-aef3-4067-9bd0-149f92f0de00.zip

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

DEFA14A 1 d595151ddefa14a.htm DEFA14A DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐

Check the appropriate box:

Preliminary Proxy Statement
Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to § 240.14a-11(c) or § 240.14a-12

DARÉ BIOSCIENCE, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
Fee paid previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:

***** Exercise Your** Right **to Vote *****

Important Notice Regarding the Availability of Proxy Materials for the

Stockholder Meeting to Be Held on July 10, 2018.

Meeting Information
DARÉ BIOSCIENCE, INC. Meeting Type: Annual Meeting
For holders as of: May 11, 2018
Date: July 10, 2018 Time: 9:00 a.m. Pacific Time
DARÉ BIOSCIENCE, INC. 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA, CA 92037 Location: Meeting live via the
Internet-please visit www.virtualshareholdermeeting.com/DARE2018. The company will be hosting the meeting live via the Internet this year.
To attend the meeting via the Internet please visit www.virtualshareholdermeeting.com/DARE2018 and be sure to have the information that is printed in the box marked by the arrow (located on the following page).
You are receiving this communication because you hold shares in the company named above. This is not a ballot. You cannot use this notice to vote
these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see
reverse side). We encourage you to access and review
all of the important information contained in the proxy materials before voting.
See the
reverse side of this notice to obtain proxy materials and voting instructions.
— Before You Vote — How to Access the Proxy Materials
Proxy Materials
Available to VIEW or RECEIVE:
NOTICE AND PROXY
STATEMENT ANNUAL REPORT How to
View Online:
Have the information that is printed in the box marked by the arrow (located on the following page) and visit: www.proxyvote.com. How to Request and Receive a PAPER or E-MAIL Copy: If you want to receive a paper or e-mail copy of these
documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
1) BY INTERNET : www.proxyvote.com
2) BY TELEPHONE : 1-800-579-1639
3) BY E-MAIL* : [email protected]
*  If requesting materials by e-mail, please send a blank e-mail with the information that
is printed in the box marked by the arrow (located on the following page) in the subject line. Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the
request as instructed above on or before June 26, 2018 to facilitate timely delivery.
— How To Vote —
Please Choose One of the Following Voting Methods
Vote In Internet: Before The
Meeting: Go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions. During The
Meeting: Go to www.virtualshareholdermeeting.com/DARE2018. Have the information that is printed in the box
marked by the arrow (located on the following page) available and follow the instructions. Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

Voting Items

1. Election of Class I Directors Nominees: 01) Jessica D. Grossman, M.D. 02) Susan L. Kelley, M.D.
The Board of Directors recommends you vote FOR the following proposals:
2. To approve the Daré Bioscience, Inc. Amended and Restated 2014 Stock Incentive Plan.
3. To ratify the selection of Mayer Hoffman McCann P.C. as the independent registered public accounting firm of Daré Bioscience, Inc. for the fiscal year ending December 31, 2018.